Prolight Diagnostics AB (publ) (NGM: PRLD)

Market Cap	124.83M
Revenue (ttm)	25.13M
Net Income (ttm)	-140.00M
Shares Out	597.29M
EPS (ttm)	-0.33
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,406,036
Open	n/a
Previous Close	0.228
Day's Range	n/a
52-Week Range	0.117 - 1.015
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2024

About Prolight Diagnostics AB

Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing in Sweden. It engages in the development of PLD micro flex and flex membrane. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Stockholm, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 16
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: PRLD

Financial Performance

In 2023, Prolight Diagnostics AB's revenue was 24.22 million, a decrease of -31.35% compared to the previous year's 35.27 million. Losses were -135.46 million, 1003.5% more than in 2022.